313 related articles for article (PubMed ID: 31506635)
1. RIP1/RIP3/MLKL mediates dopaminergic neuron necroptosis in a mouse model of Parkinson disease.
Lin QS; Chen P; Wang WX; Lin CC; Zhou Y; Yu LH; Lin YX; Xu YF; Kang DZ
Lab Invest; 2020 Mar; 100(3):503-511. PubMed ID: 31506635
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice.
Oliveira SR; Dionísio PA; Gaspar MM; Ferreira MBT; Rodrigues CAB; Pereira RG; Estevão MS; Perry MJ; Moreira R; Afonso CAM; Amaral JD; Rodrigues CMP
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069782
[TBL] [Abstract][Full Text] [Related]
3. PI3K mediates tumor necrosis factor induced-necroptosis through initiating RIP1-RIP3-MLKL signaling pathway activation.
Hu S; Chang X; Zhu H; Wang D; Chen G
Cytokine; 2020 May; 129():155046. PubMed ID: 32114297
[TBL] [Abstract][Full Text] [Related]
4. RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin.
Shrestha A; Mehdizadeh Gohari I; McClane BA
mBio; 2019 Dec; 10(6):. PubMed ID: 31848291
[No Abstract] [Full Text] [Related]
5. Inhibition of neuronal necroptosis mediated by RIP1/RIP3/MLKL provides neuroprotective effects on kaolin-induced hydrocephalus in mice.
Liu C; Chen Y; Cui W; Cao Y; Zhao L; Wang H; Liu X; Fan S; Huang K; Tong A; Zhou L
Cell Prolif; 2021 Sep; 54(9):e13108. PubMed ID: 34374150
[TBL] [Abstract][Full Text] [Related]
6. Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice.
Marunouchi T; Nishiumi C; Iinuma S; Yano E; Tanonaka K
Eur J Pharmacol; 2021 May; 898():173987. PubMed ID: 33640405
[TBL] [Abstract][Full Text] [Related]
7. Necrostatin-1 Protects Against Paraquat-Induced Cardiac Contractile Dysfunction via RIP1-RIP3-MLKL-Dependent Necroptosis Pathway.
Zhang L; Feng Q; Wang T
Cardiovasc Toxicol; 2018 Aug; 18(4):346-355. PubMed ID: 29299822
[TBL] [Abstract][Full Text] [Related]
8. GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma.
Liu M; Li H; Yang R; Ji D; Xia X
J Neuroinflammation; 2022 Oct; 19(1):262. PubMed ID: 36289519
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits necroptosis by mediating the TNF-α/RIP1/RIP3/MLKL pathway in myocardial hypoxia/reoxygenation injury.
Hu Y; Pan H; Peng J; He J; Tang M; Yan S; Rong J; Li J; Zheng Z; Wang H; Liu Y; Zhong X
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(4):430-437. PubMed ID: 33686403
[TBL] [Abstract][Full Text] [Related]
10. Receptor-interacting protein 3-phosphorylated Ca
Yuan G; Cao C; Cao D; Li B; Li X; Li H; Shen H; Wang Z; Chen G
J Neurochem; 2023 Jan; 164(1):94-114. PubMed ID: 36424866
[TBL] [Abstract][Full Text] [Related]
11. Catalytically inactive RIP1 and RIP3 deficiency protect against acute ischemic stroke by inhibiting necroptosis and neuroinflammation.
Zhang Y; Li M; Li X; Zhang H; Wang L; Wu X; Zhang H; Luo Y
Cell Death Dis; 2020 Jul; 11(7):565. PubMed ID: 32703968
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic neuronal death via necroptosis in Parkinson's disease: A review of the literature.
Regoni M; Valtorta F; Sassone J
Eur J Neurosci; 2024 Mar; 59(6):1079-1098. PubMed ID: 37667848
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis.
Wu XN; Yang ZH; Wang XK; Zhang Y; Wan H; Song Y; Chen X; Shao J; Han J
Cell Death Differ; 2014 Nov; 21(11):1709-20. PubMed ID: 24902902
[TBL] [Abstract][Full Text] [Related]
14. Nuclear translocation of MLKL enhances necroptosis by a RIP1/RIP3-independent mechanism in H9c2 cardiomyoblasts.
Ino S; Yano T; Kuno A; Tanno M; Kouzu H; Sato T; Yamashita T; Ohwada W; Osanami A; Ogawa T; Toda Y; Shimizu M; Miura T
J Pharmacol Sci; 2023 Feb; 151(2):134-143. PubMed ID: 36707179
[TBL] [Abstract][Full Text] [Related]
15. Necrostatin-1 accelerates time to death in a rat model of cecal ligation and puncture and massively increases hepatocyte caspase-3 cleavage.
Zhang Q; Wei S; Lu J; Fu W; Chen H; Huang Q; Chen Z; Zeng Z
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G551-G561. PubMed ID: 30735454
[TBL] [Abstract][Full Text] [Related]
16. A Role for Tubular Necroptosis in Cisplatin-Induced AKI.
Xu Y; Ma H; Shao J; Wu J; Zhou L; Zhang Z; Wang Y; Huang Z; Ren J; Liu S; Chen X; Han J
J Am Soc Nephrol; 2015 Nov; 26(11):2647-58. PubMed ID: 25788533
[TBL] [Abstract][Full Text] [Related]
17. Necrosulfonamide exerts neuroprotective effect by inhibiting necroptosis, neuroinflammation, and α-synuclein oligomerization in a subacute MPTP mouse model of Parkinson's disease.
Leem YH; Kim DY; Park JE; Kim HS
Sci Rep; 2023 May; 13(1):8783. PubMed ID: 37258791
[TBL] [Abstract][Full Text] [Related]
18. Necroptosis in health and diseases.
Zhou W; Yuan J
Semin Cell Dev Biol; 2014 Nov; 35():14-23. PubMed ID: 25087983
[TBL] [Abstract][Full Text] [Related]
19. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.
Chen W; Zhou Z; Li L; Zhong CQ; Zheng X; Wu X; Zhang Y; Ma H; Huang D; Li W; Xia Z; Han J
J Biol Chem; 2013 Jun; 288(23):16247-16261. PubMed ID: 23612963
[TBL] [Abstract][Full Text] [Related]
20. Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson's disease.
Dionísio PA; Oliveira SR; Gaspar MM; Gama MJ; Castro-Caldas M; Amaral JD; Rodrigues CMP
Cell Death Dis; 2019 Nov; 10(11):840. PubMed ID: 31690718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
